If immunotherapy has the cancer community riveted on the treatment side, liquid biopsies are equally exciting on the diagnostics end. And IBM is bringing its research heft to bear on the world of liquid biopsy with an intent to build a lab-on-a-chip technology that can separate particles at the nanoscale.
{iframe}http://medcitynews.com/2016/08/ibm-liquid-biopsy/?utm_source=hs_email&utm_medium=email&utm_content=32584576&_hsenc=p2ANqtz–oMgp4ssADsGdUMknxPPSNfgwNPIGG96cHlrxHFlBe96xI8Tv2ctdyHO5UVS-cvp0h1Un6jHfXc_nObh_5xXtpyKi5cw&_hsmi=32584576{/iframe}